Literature DB >> 19348623

Mutations in the lamin B1 gene are not present in multiple sclerosis.

A Brussino1, S D'Alfonso, C Cagnoli, E Di Gregorio, M Barberis, S Padovan, G Vaula, L Pinessi, S Squadrone, M C Abete, L Collimedaglia, F R Guerini, N Migone, A Brusco.   

Abstract

BACKGROUND: Whole gene duplication of the lamin B1 gene (LMNB1), encoding for a protein of the nuclear lamina, causes an adult-onset autosomal dominant leukodystrophy (ADLD). Clinical features of ADLD (onset in adult life, dysautonomic symptoms, followed by pyramidal and cerebellar dysfunctions) partially resemble those of multiple sclerosis (MS), particularly the primary-progressive form. Our aim was to test whether LMNB1 gene mutations were present amongst patients with a diagnosis of MS.
METHODS: One hundred eighty-two MS patients were screened for copy number variations of the LMNB1 gene using a qPCR assay. Point mutations in the LMNB1 gene were searched by denaturing high-performance liquid chromatography and direct sequencing in a subgroup of 16 patients with familial MS.
RESULTS: No duplication/deletion of the lamin B1 gene was found amongst MS patients, and no point mutation was identified in the familial cases.
CONCLUSION: Our work indicates that lamin B1 defects are probably not responsible for signs and symptoms resembling multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19348623     DOI: 10.1111/j.1468-1331.2009.02536.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  2 in total

Review 1.  Adult-onset autosomal dominant leukodystrophy: linking nuclear envelope to myelin.

Authors:  Shu-Ting Lin; Louis J Ptácek; Ying-Hui Fu
Journal:  J Neurosci       Date:  2011-01-26       Impact factor: 6.167

2.  Lamin B1 overexpression increases nuclear rigidity in autosomal dominant leukodystrophy fibroblasts.

Authors:  Denise Ferrera; Claudio Canale; Roberto Marotta; Nadia Mazzaro; Marta Gritti; Michele Mazzanti; Sabina Capellari; Pietro Cortelli; Laura Gasparini
Journal:  FASEB J       Date:  2014-05-22       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.